JP2016505551A5 - - Google Patents

Download PDF

Info

Publication number
JP2016505551A5
JP2016505551A5 JP2015545760A JP2015545760A JP2016505551A5 JP 2016505551 A5 JP2016505551 A5 JP 2016505551A5 JP 2015545760 A JP2015545760 A JP 2015545760A JP 2015545760 A JP2015545760 A JP 2015545760A JP 2016505551 A5 JP2016505551 A5 JP 2016505551A5
Authority
JP
Japan
Prior art keywords
alkyl
group
heterocyclyl
cycloalkyl
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015545760A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016505551A (ja
JP6283862B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/075238 external-priority patent/WO2014086712A1/en
Publication of JP2016505551A publication Critical patent/JP2016505551A/ja
Publication of JP2016505551A5 publication Critical patent/JP2016505551A5/ja
Application granted granted Critical
Publication of JP6283862B2 publication Critical patent/JP6283862B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015545760A 2012-12-07 2013-12-02 新規インダニルオキシジヒドロベンゾフラニル酢酸 Expired - Fee Related JP6283862B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12196011 2012-12-07
EP12196011.6 2012-12-07
PCT/EP2013/075238 WO2014086712A1 (en) 2012-12-07 2013-12-02 New indanyloxydihydrobenzofuranylacetic acids

Publications (3)

Publication Number Publication Date
JP2016505551A JP2016505551A (ja) 2016-02-25
JP2016505551A5 true JP2016505551A5 (enExample) 2017-01-19
JP6283862B2 JP6283862B2 (ja) 2018-02-28

Family

ID=47290800

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015545760A Expired - Fee Related JP6283862B2 (ja) 2012-12-07 2013-12-02 新規インダニルオキシジヒドロベンゾフラニル酢酸

Country Status (7)

Country Link
US (2) US20140163025A1 (enExample)
EP (1) EP2928886B1 (enExample)
JP (1) JP6283862B2 (enExample)
AR (1) AR093864A1 (enExample)
TW (1) TW201439076A (enExample)
UY (1) UY35171A (enExample)
WO (1) WO2014086712A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014086712A1 (en) 2012-12-07 2014-06-12 Boehringer Ingelheim International Gmbh New indanyloxydihydrobenzofuranylacetic acids
PE20160434A1 (es) 2013-09-09 2016-05-25 Peloton Therapeutics Inc Eteres de arilo y sus usos
AP2016009176A0 (en) 2013-11-14 2016-04-30 Cadila Healthcare Ltd Novel heterocyclic compounds
ES2737148T3 (es) 2013-12-16 2020-01-10 Peloton Therapeutics Inc Análogos de sulfona y sulfoximina cíclicos y usos de los mismos
CN104177320B (zh) * 2014-08-27 2016-03-02 广东东阳光药业有限公司 一种脲取代联苯类化合物及其组合物及用途
WO2016145032A1 (en) 2015-03-11 2016-09-15 Peloton Therapeutics, Inc. Compositions for use in treating pulmonary arterial hypertension
WO2016144825A1 (en) 2015-03-11 2016-09-15 Peloton Therapeutics, Inc. Aromatic compounds and uses thereof
EP3268362B1 (en) 2015-03-11 2021-10-20 Peloton Therapeutics, Inc. Substituted pyridines and uses thereof
US10512626B2 (en) 2015-03-11 2019-12-24 Peloton Therapeautics, Inc. Compositions for use in treating glioblastoma
WO2016168510A1 (en) 2015-04-17 2016-10-20 Peloton Therapeutics, Inc. Combination therapy of a hif-2-alpha inhibitor and an immunotherapeutic agent and uses thereof
EA035867B1 (ru) * 2016-04-29 2020-08-24 Байер Фарма Акциенгезельшафт Синтез индазолов
PE20240651A1 (es) * 2016-04-29 2024-04-04 Bayer Pharma AG Sintesis de indazoles
CN110248929B (zh) 2017-01-26 2023-05-12 勃林格殷格翰国际有限公司 苄基氨基吡嗪基环丙烷甲酸、其药物组合物和用途
US10603317B2 (en) 2017-01-26 2020-03-31 Boehringer Ingelheim International Gmbh Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
US10919859B2 (en) 2017-01-26 2021-02-16 Boehringer Ingelheim International Gmbh Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
US10913720B2 (en) 2017-01-26 2021-02-09 Boehringer Ingelheim International Gmbh Benzyloxypyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
CN110300755B (zh) 2017-02-08 2022-10-04 勃林格殷格翰国际有限公司 茚满基氨基氮杂二氢苯并呋喃乙酸、用于治疗糖尿病的药物组合物
WO2018167800A1 (en) * 2017-03-13 2018-09-20 Impetis Biosciences Limited Fused bicyclic compounds, compositions and applications thereof
CN111712494A (zh) 2018-02-13 2020-09-25 吉利德科学公司 Pd-1/pd-l1抑制剂
EP4600247A3 (en) 2018-04-19 2025-11-19 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
KR20230159715A (ko) 2018-07-13 2023-11-21 길리애드 사이언시즈, 인코포레이티드 Pd-1/pd-l1 억제제
AU2019366355B2 (en) 2018-10-24 2022-10-13 Gilead Sciences, Inc. PD-1/PD-L1 inhibitors
WO2021071837A1 (en) 2019-10-07 2021-04-15 Kallyope, Inc. Gpr119 agonists
BR112022017039A2 (pt) 2020-02-28 2022-11-16 Kallyope Inc Agonistas de gpr40
JP2023526625A (ja) 2020-05-19 2023-06-22 キャリーオペ,インク. Ampkアクチベーター
CN116390925A (zh) 2020-06-26 2023-07-04 卡尔优普公司 Ampk活化剂

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960369B2 (en) 2002-11-08 2011-06-14 Takeda Pharmaceutical Company Limited Receptor function regulator
US7135575B2 (en) 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
JP4805552B2 (ja) * 2003-05-30 2011-11-02 武田薬品工業株式会社 縮合環化合物
EP1630152A4 (en) 2003-05-30 2009-09-23 Takeda Pharmaceutical CONDENSED CYCLIC COMPOUND
CA2560111A1 (en) * 2004-03-15 2005-09-22 Takeda Pharmaceutical Company Limited Aminophenylpropanoic acid derivative
EP1924546A1 (en) * 2005-09-14 2008-05-28 Amgen, Inc Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
MX2008012529A (es) 2006-03-30 2008-10-14 Asahi Kasei Pharma Corp Derivado biciclico substituido y uso del mismo.
JP4401428B2 (ja) 2006-06-27 2010-01-20 武田薬品工業株式会社 縮合環化合物
EP2289868B1 (en) 2008-06-25 2014-08-13 Daiichi Sankyo Company, Limited Carboxylic acid compound
ES2450567T3 (es) 2008-10-15 2014-03-25 Amgen, Inc Moduladores de GPR40 espirocíclicos
WO2010143733A1 (en) 2009-06-09 2010-12-16 Takeda Pharmaceutical Company Limited Novel fused cyclic compound and use thereof
TW201643169A (zh) 2010-07-09 2016-12-16 艾伯維股份有限公司 作為s1p調節劑的螺-哌啶衍生物
US20120302566A1 (en) 2010-12-01 2012-11-29 Boehringer Ingelheim International Gmbh Indanyloxydihydrobenzofuranylacetic acids
BR112015009376A2 (pt) * 2012-11-28 2017-07-04 Boehringer Ingelheim Int ácidos indaniloxidihidrobenzofuranilacéticos
WO2014086712A1 (en) 2012-12-07 2014-06-12 Boehringer Ingelheim International Gmbh New indanyloxydihydrobenzofuranylacetic acids

Similar Documents

Publication Publication Date Title
JP2016505551A5 (enExample)
RU2403258C2 (ru) Тиазолилдигидроиндазолы
US20130096056A1 (en) Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
JP2015511613A5 (enExample)
RU2011109190A (ru) Бензоксазолы, бензтиазолы и родственные аналоги в качестве модуляторов сиртуина
RU2019123031A (ru) (аза)индол-, бензотиофен- и бензофуран-3-сульфонамиды
TW200617001A (en) Novel glucitol derivative, its prodrug, their salt and diabetic therapeutic agent containing the same
JP2013510825A5 (enExample)
RU2011153772A (ru) Фторированные аминотриазольные производные
ZA200503501B (en) Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases
WO1998052611A1 (en) Medicinal composition for prevention or treatment of hepatopathy
JP2009263394A5 (enExample)
RU2002131887A (ru) Замещенные в орто-положении амиды антраниловой кислоты и их применение в качестве лекарственных средств
JP2011519863A5 (enExample)
JP2006520755A5 (enExample)
JP2002523371A (ja) ウイルス感染および関連疾患を治療または予防するための化合物、組成物および方法
JP2011521911A5 (enExample)
JP2009535307A5 (enExample)
RU2001116594A (ru) Пестициды
JP2014532626A5 (enExample)
JP2012519691A5 (enExample)
RU2010134411A (ru) Фенилацетамидное производное
JP2018509474A (ja) インダン酢酸誘導体を用いる肝疾患の治療方法
RU2008107733A (ru) Ингибиторы gsk-3
JP2020513415A5 (enExample)